Mounjaro Injection (generic name: Tirzepatide) is a breakthrough once-weekly injectable medication initially developed for Type 2 diabetes management. However, it has also shown significant potential for weight loss, becoming one of the most talked-about medical solutions in 2025. It works by targeting two critical hormones — GIP (glucose-dependent insulinotropic polypeptide)...